In a report published Tuesday, Morgan Stanley analyst Bin Li reiterated an Underweight rating on Concord Medical Services Holdings Ltd. CCM, but removed the $7.00 price target.
In the report, Morgan Stanley noted, “CCM's 3Q14 non-GAAP EPS of Rmb0.72 beat our estimate by 25%, mainly due to lower G&A expenses caused by the collection of bad debt. Management reiterated 2014 guidance of EPS of US$0.45-0.50 (+25-38% YoY), given the solid operation performance.”
Concord Medical Services Holdings Ltd. closed on Monday at $6.94.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in